LM-101

N/A

Report date: 2024/05/15 20:00:35

Base Information

Drug NameLM-101
Drug Alias NameLM-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Signal-regulatory protein alpha
TargetsSignal-regulatory protein alpha
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLeukemia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLaNova Medicines Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLaNova Medicines Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLeukemia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A